MAP2K7 and polycystic ovary syndrome: This statement agrees with IR (91) and is a viable candidate for AH in PCOS, considering PCOS itself is an underlying condition for P450c17 and 3-HSD regulation alongside the P450c17/3-HSD regulation with ERK/MEK signaling pathways.